📰 Into News
Page 713 - Into News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Into. Real-time updates on events, politics, business and more.
July 25, 2022
VTv Therapeutics Announces Investment by CinRx Pharma HIGH POINT, N.C.--July 25, 2022 - vTv Therapeutics Inc. today announced entry into agreements that include... | July 25, 2022
July 24, 2022
Mukkabaaz actor Vineet Kumar Singh, who will next be seen in the action-crime drama Rangbaaz 3, revealed that in order to get into character, he has begun isolating himself.
July 24, 2022
1,600 Previously Convicted Criminals Caught Crossing into Single Texas Border Sector This Year by BOB PRICE 24 Jul 2022 Del Rio Sector Border Patrol
July 24, 2022
Trading sessions in the month of July were painful to watch for commodities and precious metals investors. The Gold chart is showing a continuous decline after the price was rejected at $1850 mid-June.
July 23, 2022
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, NEW ZEALAND OR ANY... | July 23, 2022
July 23, 2022
Bharatiya Janata Partys Bharatpur MP Ranjeeta Koli on Saturday demanded Central Bureau of Investigation (CBI) probe into the death of a seer, who set himself ablaze against illegal mining in Rajasthan and hit out at Chief Minister Ashok Gehlot over inaction of the government for not looking into protests for over 500 days.
July 22, 2022
Delhis Lieutenant Governor Vinai Kumar Saxena has recommended an investigation by the Central Bureau of Investigation into the alleged violations of the Arvind Kejriwal-led governments new contentious excise policy including deliberate and gross procedural lapses made by deputy chief minister Manish Sisodia to provide post tender undue benefits to liquor licensees.
July 21, 2022
The ministry of urban and rural development will launch an inquiry into Windhoek mayor Sade Gawanas after it came to light that she had received a transport allowance while also...
July 21, 2022
NeuroFront receives an exclusive option for an exclusive license to develop, commercialize and manufacture NRD.E1, Novaremed's first-in-class, non-opioid investigational drug for the treatment of
July 21, 2022
PARIS (dpa-AFX) - Innate Pharma SA (IPHA) said Sanofi (SNYNF, SNY) has made the decision to progress IPH6401/SAR'514 into investigational new drug-enabling studies, triggering a 3 million euros